Go Pro

Definitive Healthcare (DH) Competitors

Definitive Healthcare logo
$0.70 +0.02 (+2.45%)
As of 02:19 PM Eastern
This is a fair market value price provided by Massive. Learn more.

DH vs. AMWL, HCAT, OPRX, CCLD, and HIT

Should you buy Definitive Healthcare stock or one of its competitors? MarketBeat compares Definitive Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Definitive Healthcare include American Well (AMWL), Health Catalyst (HCAT), OptimizeRx (OPRX), CareCloud (CCLD), and Health In Tech (HIT). These companies are all part of the "healthcare technology" industry.

How does Definitive Healthcare compare to American Well?

American Well (NYSE:AMWL) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

American Well presently has a consensus target price of $8.60, suggesting a potential downside of 37.07%. Definitive Healthcare has a consensus target price of $2.47, suggesting a potential upside of 252.06%. Given Definitive Healthcare's higher possible upside, analysts plainly believe Definitive Healthcare is more favorable than American Well.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
American Well
1 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Definitive Healthcare
4 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
1.89

American Well has higher revenue and earnings than Definitive Healthcare. American Well is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Well$249.32M0.91-$95.70M-$4.77N/A
Definitive Healthcare$241.52M0.31-$138.93M-$1.62N/A

American Well has a net margin of -35.75% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat American Well's return on equity.

Company Net Margins Return on Equity Return on Assets
American Well-35.75% -30.12% -22.30%
Definitive Healthcare -76.04%4.04%1.99%

American Well has a beta of 1.68, indicating that its share price is 68% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market.

In the previous week, American Well had 9 more articles in the media than Definitive Healthcare. MarketBeat recorded 12 mentions for American Well and 3 mentions for Definitive Healthcare. American Well's average media sentiment score of 0.65 beat Definitive Healthcare's score of 0.00 indicating that American Well is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
American Well
1 Very Positive mention(s)
5 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Definitive Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

56.1% of American Well shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 12.8% of American Well shares are owned by insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

American Well and Definitive Healthcare tied by winning 8 of the 16 factors compared between the two stocks.

How does Definitive Healthcare compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Definitive Healthcare has lower revenue, but higher earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Catalyst$311.14M0.42-$177.97M-$3.72N/A
Definitive Healthcare$241.52M0.31-$138.93M-$1.62N/A

Health Catalyst has a beta of 1.55, indicating that its stock price is 55% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market.

Health Catalyst presently has a consensus target price of $2.93, indicating a potential upside of 66.11%. Definitive Healthcare has a consensus target price of $2.47, indicating a potential upside of 252.06%. Given Definitive Healthcare's higher possible upside, analysts plainly believe Definitive Healthcare is more favorable than Health Catalyst.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Catalyst
1 Sell rating(s)
8 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.23
Definitive Healthcare
4 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
1.89

In the previous week, Health Catalyst had 8 more articles in the media than Definitive Healthcare. MarketBeat recorded 11 mentions for Health Catalyst and 3 mentions for Definitive Healthcare. Health Catalyst's average media sentiment score of 0.36 beat Definitive Healthcare's score of 0.00 indicating that Health Catalyst is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health Catalyst
0 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Definitive Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 19.4% of Health Catalyst shares are held by insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Definitive Healthcare has a net margin of -76.04% compared to Health Catalyst's net margin of -87.69%. Definitive Healthcare's return on equity of 4.04% beat Health Catalyst's return on equity.

Company Net Margins Return on Equity Return on Assets
Health Catalyst-87.69% -3.52% -1.77%
Definitive Healthcare -76.04%4.04%1.99%

Summary

Definitive Healthcare beats Health Catalyst on 9 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to OptimizeRx?

Definitive Healthcare (NASDAQ:DH) and OptimizeRx (NASDAQ:OPRX) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

In the previous week, Definitive Healthcare and Definitive Healthcare both had 3 articles in the media. OptimizeRx's average media sentiment score of 0.84 beat Definitive Healthcare's score of 0.00 indicating that OptimizeRx is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Definitive Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
OptimizeRx
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Definitive Healthcare has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

Definitive Healthcare currently has a consensus price target of $2.47, indicating a potential upside of 252.06%. OptimizeRx has a consensus price target of $13.43, indicating a potential upside of 90.96%. Given Definitive Healthcare's higher probable upside, equities research analysts clearly believe Definitive Healthcare is more favorable than OptimizeRx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Definitive Healthcare
4 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
1.89
OptimizeRx
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56

OptimizeRx has a net margin of 6.37% compared to Definitive Healthcare's net margin of -76.04%. OptimizeRx's return on equity of 10.86% beat Definitive Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Definitive Healthcare-76.04% 4.04% 1.99%
OptimizeRx 6.37%10.86%7.93%

98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 17.1% of Definitive Healthcare shares are held by insiders. Comparatively, 7.5% of OptimizeRx shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

OptimizeRx has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Definitive Healthcare$241.52M0.31-$138.93M-$1.62N/A
OptimizeRx$109.43M1.21$5.13M$0.3520.09

Summary

OptimizeRx beats Definitive Healthcare on 10 of the 16 factors compared between the two stocks.

How does Definitive Healthcare compare to CareCloud?

Definitive Healthcare (NASDAQ:DH) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

Definitive Healthcare has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market.

In the previous week, CareCloud had 3 more articles in the media than Definitive Healthcare. MarketBeat recorded 6 mentions for CareCloud and 3 mentions for Definitive Healthcare. CareCloud's average media sentiment score of 0.53 beat Definitive Healthcare's score of 0.00 indicating that CareCloud is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Definitive Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CareCloud
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 10.2% of CareCloud shares are held by institutional investors. 17.1% of Definitive Healthcare shares are held by insiders. Comparatively, 14.8% of CareCloud shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Definitive Healthcare presently has a consensus price target of $2.47, suggesting a potential upside of 252.06%. CareCloud has a consensus price target of $3.25, suggesting a potential upside of 24.76%. Given Definitive Healthcare's higher probable upside, research analysts plainly believe Definitive Healthcare is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Definitive Healthcare
4 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
1.89
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

CareCloud has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Definitive Healthcare$241.52M0.31-$138.93M-$1.62N/A
CareCloud$124.14M0.89$10.80M$0.1123.68

CareCloud has a net margin of 7.87% compared to Definitive Healthcare's net margin of -76.04%. CareCloud's return on equity of 24.05% beat Definitive Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Definitive Healthcare-76.04% 4.04% 1.99%
CareCloud 7.87%24.05%16.38%

Summary

CareCloud beats Definitive Healthcare on 11 of the 16 factors compared between the two stocks.

How does Definitive Healthcare compare to Health In Tech?

Health In Tech (NASDAQ:HIT) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and media sentiment.

In the previous week, Definitive Healthcare had 2 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for Definitive Healthcare and 1 mentions for Health In Tech. Health In Tech's average media sentiment score of 0.00 equaled Definitive Healthcare'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health In Tech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Definitive Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Health In Tech currently has a consensus target price of $4.00, indicating a potential upside of 253.98%. Definitive Healthcare has a consensus target price of $2.47, indicating a potential upside of 252.06%. Given Health In Tech's stronger consensus rating and higher probable upside, equities analysts plainly believe Health In Tech is more favorable than Definitive Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health In Tech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
Definitive Healthcare
4 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
1.89

Health In Tech has higher earnings, but lower revenue than Definitive Healthcare. Health In Tech is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health In Tech$34.08M2.17-$1.31M-$0.02N/A
Definitive Healthcare$241.52M0.31-$138.93M-$1.62N/A

98.7% of Definitive Healthcare shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Health In Tech has a beta of 2.82, meaning that its stock price is 182% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market.

Health In Tech has a net margin of 0.00% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Health In Tech's return on equity.

Company Net Margins Return on Equity Return on Assets
Health In TechN/A N/A N/A
Definitive Healthcare -76.04%4.04%1.99%

Summary

Health In Tech beats Definitive Healthcare on 8 of the 15 factors compared between the two stocks.

Get Definitive Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for DH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DH vs. The Competition

MetricDefinitive HealthcareHealthcare Technology IndustryHealthcare SectorNASDAQ Exchange
Market Cap$74.50M$1.55B$6.96B$12.95B
Dividend YieldN/A4.74%2.59%9.93%
P/E Ratio-0.4423.41270.8325.99
Price / Sales0.3168.85663.11111.01
Price / Cash0.3430.9271.8950.37
Price / Book0.265.9313.196.22
Net Income-$138.93M-$25.90M$3.45B$342.55M
7 Day Performance2.89%7.58%4.32%4.17%
1 Month Performance-22.00%1.21%-1.87%-1.15%
1 Year Performance-82.32%-17.83%76.76%22.24%

Definitive Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DH
Definitive Healthcare
2.3355 of 5 stars
$0.70
+2.5%
$2.47
+252.1%
-82.6%$74.50M$241.52MN/A970
AMWL
American Well
2.2672 of 5 stars
$10.26
-4.7%
$8.60
-16.1%
+62.8%$168.89M$249.32MN/A1,040
HCAT
Health Catalyst
3.8617 of 5 stars
$2.24
+1.1%
$2.93
+31.2%
-39.5%$165.14M$311.14MN/A1,200
OPRX
OptimizeRx
4.4869 of 5 stars
$6.87
+4.8%
$13.43
+95.6%
-46.0%$128.77M$109.43M19.61100
CCLD
CareCloud
3.4847 of 5 stars
$2.60
-2.1%
$3.25
+25.2%
-9.2%$110.31M$124.14M23.603,650

Related Companies and Tools


This page (NASDAQ:DH) was last updated on 8/7/2026 by MarketBeat.com Staff.
From Our Partners